<DOC>
	<DOC>NCT02054260</DOC>
	<brief_summary>The aim of this study is to assess of effect of Surgicel® (Fibrillar) for preventing delayed bleeding after endoscopic hemostasis in non-variceal upper gastrointestinal bleeding</brief_summary>
	<brief_title>Surgicel® (Fibrillar) in Non-variceal UGI Bleeding</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<criteria>Patients with non variceal upper gastrointestinal bleeding proven by esophagogastroduodenoscopy Patients with active bleeding (Forrest classification Ia or Ib or IIa) Patients with upper gastrointestinal tract malignancy Patients with acute severe illness Coagulopathy: liver cirrhosis, thrombocytopenia Pregnant women</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>